Acuren Corp. Announces Officer and Director Changes
Ticker: TICAW · Form: 8-K · Filed: Apr 15, 2025 · CIK: 2032966
| Field | Detail |
|---|---|
| Company | Acuren Corp (TICAW) |
| Form Type | 8-K |
| Filed Date | Apr 15, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: management-change, governance
TL;DR
Acuren Corp. shuffled its execs and board on 4/11. New comp plans too.
AI Summary
Acuren Corp. announced on April 11, 2025, changes in its officer and director positions. The filing details the departure of certain officers and directors, the election of new directors, and updates to compensatory arrangements for its officers.
Why It Matters
Changes in corporate leadership and compensation structures can signal shifts in company strategy or governance, potentially impacting investor confidence and future performance.
Risk Assessment
Risk Level: low — This filing reports routine corporate governance changes and does not involve significant financial transactions or operational disruptions.
Key Players & Entities
- Acuren Corp. (company) — Registrant
- Delaware (jurisdiction) — State of incorporation
- 14434 Medical Complex Drive, Suite 100, Tomball, Texas 77377 (address) — Principal executive offices
FAQ
What specific officers and directors have departed from Acuren Corp. as of April 11, 2025?
The filing indicates the departure of certain officers and directors, but does not name them specifically in the provided text.
Who has been elected as new directors to Acuren Corp.'s board?
The filing states that directors have been elected, but does not provide their names in the excerpt.
Are there any changes to the compensatory arrangements for Acuren Corp.'s officers?
Yes, the filing mentions updates to the compensatory arrangements of certain officers.
What is the principal executive office address for Acuren Corp.?
The principal executive offices are located at 14434 Medical Complex Drive, Suite 100, Tomball, Texas 77377.
What is Acuren Corp.'s fiscal year end?
Acuren Corp.'s fiscal year ends on December 31st.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 15, 2025 regarding ACUREN CORP (TICAW).